Found 9 matching trials
A Phase II Clinical Study of HRS-7058 in Combination With Antitumor Drugs in Patients With Advanced Malignant Tumour PHASE2 This study is a multicentre, open phase II clinical study of dose escalatio...
Show More Location
Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors PHASE1 This study is an open-label, multicenter Phase IB/II clinical trial to eval...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
A IB/II Phase Clinical Study on the Safety, Tolerability, and Efficacy of SHR-9839(sc) in Combination Anti-tumor Therapy in Patients With Solid Tumors PHASE1 This study is an open-label, multi-center Phase IB/II clinical trial of SHR...
Show More Location
The First Affiliated Hospital of Nanjing Medical University, Jiangsu Provincial People's Hospital
Learn More & Join Trial
A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With NSCLC PHASE1 This is an open label, multi-center, multiple dose Phase IB/II study to eva...
Show More Location
Shanghai Chest Hospital
Learn More & Join Trial
A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors PHASE1 This is an open label, multi-center, multiple dose Phase IB/II study to eva...
Show More Location
Sun Yat-Sen university cancer center
Learn More & Join Trial
A Study of HRS-4642 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation PHASE1 The study is being conducted to evaluate the safety, tolerability, and effi...
Show More Status
Active Not Recruiting
Location
Shanghai East Hospital
Learn More & Join Trial
A Trial of SHR-A2102 With Adebrelimab With or Without Other Anti-tumor Therapies in Recurrent/MetastaticHead and Neck Squamous Cell Carcinoma Cancer PHASE1 The study is being conducted to evaluate the safety, tolerability and effic...
Show More Location
Chongqing University Cancer Hospital
Learn More & Join Trial
The Clinical Study of SHR-9839 for Injection in Patients With Advanced Solid Tumors PHASE1 This study is an open-label, phase I clinical trial of SHR-9839 in patients...
Show More Location
Zhejiang Tumor Hospital
Learn More & Join Trial
A Clinical Study of SHR-9839 as Monotherapy or in Combination With Chemotherapy Plus Adebrelimab Versus Chemotherapy Plus Adebrelimab in Patients With Advanced Esophageal Squamous Cell Carcinoma PHASE2 An open-label, multicenter, randomized, phase II clinical trial to evaluate...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial